NRIX
Nurix Therapeutics, Inc.Company with tickers: NRIX
CIK
1549595
CUSIP
67080M103
Shares Outstanding
103,405,813
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-15 | Silva Paul M | SVP & Chief Accounting Officer | Award | 31,250 |
| 2026-05-15 | DANSEY ROGER D | Director | Award | 31,250 |
| 2026-05-15 | GREGORY JULIA P | Director | Award | 31,250 |
| 2026-05-15 | Saltzman Edward C | Director | Award | 31,250 |
| 2026-05-15 | Lacey David L. | Director | Award | 31,250 |
| 2026-05-15 | Baynes Roy D. | Chief Medical Officer | Award | 31,250 |
| 2026-05-15 | Reinsdorf Judith A | Director | Award | 31,250 |
| 2026-05-15 | Kapur Anil | Director | Award | 31,250 |
| 2026-05-05 | van Houte Hans | Chief Financial Officer | Sell | 13,473 |
| 2026-05-05 | van Houte Hans | Chief Financial Officer | Sell | 582 |
| 2026-05-04 | Ring Christine | Chief Legal Officer | Sell | 8,148 |
| 2026-05-01 | Ring Christine | Chief Legal Officer | Sell | 5,394 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,750 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 3,750 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 2,858 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 2,000 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 2,000 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 3,750 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Convert | 2,858 |
| 2026-04-30 | Ring Christine | Chief Legal Officer | Sell | 3,214 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Sell | 2,388 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 2,858 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 2,858 |
| 2026-04-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Sell | 3,214 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,000 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,858 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,000 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,750 |
| 2026-04-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,858 |
| 2026-04-02 | Ring Christine | Chief Legal Officer | Sell | 8,148 |
| 2026-03-02 | Ring Christine | Chief Legal Officer | Sell | 8,148 |
| 2026-02-10 | Ring Christine | Chief Legal Officer | Award | 93,750 |
| 2026-02-10 | Ring Christine | Chief Legal Officer | Award | 42,875 |
| 2026-02-10 | SANDS ARTHUR T | Director, President, CEO | Award | 562,500 |
| 2026-02-10 | van Houte Hans | Chief Financial Officer | Award | 93,750 |
| 2026-02-10 | van Houte Hans | Chief Financial Officer | Award | 42,875 |
| 2026-02-10 | Hansen Gwenn | Chief Scientific Officer | Award | 42,875 |
| 2026-02-10 | Hansen Gwenn | Chief Scientific Officer | Award | 93,750 |
| 2026-02-09 | Ring Christine | Chief Legal Officer | Sell | 14,261 |
| 2026-02-03 | Hansen Gwenn | Chief Scientific Officer | Convert | 31,333 |
| 2026-02-03 | Hansen Gwenn | Chief Scientific Officer | Convert | 31,333 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Sell | 73 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Sell | 3,588 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,859 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,887 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,887 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,859 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,207 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,750 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,859 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,000 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Sell | 98 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,207 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 3,750 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,859 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Sell | 4,797 |
| 2026-01-30 | Hansen Gwenn | Chief Scientific Officer | Convert | 2,000 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 2,859 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 3,750 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Sell | 4,333 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 1,925 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 3,750 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 1,925 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 2,000 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 2,000 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Sell | 88 |
| 2026-01-30 | Ring Christine | Chief Legal Officer | Convert | 2,859 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2026-01-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2026-01-20 | Ring Christine | Chief Legal Officer | Convert | 3,760 |
| 2026-01-20 | Ring Christine | Chief Legal Officer | Convert | 3,760 |
| 2026-01-20 | Ring Christine | Chief Legal Officer | Sell | 3,760 |
| 2025-12-18 | Ring Christine | Chief Legal Officer | Sell | 3,560 |
| 2025-12-18 | Ring Christine | Chief Legal Officer | Convert | 3,760 |
| 2025-12-18 | Ring Christine | Chief Legal Officer | Sell | 200 |
| 2025-12-18 | Ring Christine | Chief Legal Officer | Convert | 3,760 |
| 2025-11-24 | Ring Christine | Chief Legal Officer | Convert | 37,600 |
| 2025-11-24 | Ring Christine | Chief Legal Officer | Sell | 37,600 |
| 2025-11-24 | Ring Christine | Chief Legal Officer | Convert | 37,600 |
| 2025-11-06 | DANSEY ROGER D | Director | Other | 0 |
| 2025-11-06 | DANSEY ROGER D | Director | Award | 50,000 |
| 2025-11-03 | van Houte Hans | Chief Financial Officer | Sell | 6,284 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,858 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,886 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,858 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Sell | 3,130 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,000 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 3,750 |
| 2025-10-30 | van Houte Hans | Chief Financial Officer | Convert | 2,886 |
| 2025-10-30 | Ring Christine | Chief Legal Officer | Convert | 2,858 |
| 2025-10-30 | Ring Christine | Chief Legal Officer | Convert | 3,750 |
| 2025-10-30 | Ring Christine | Chief Legal Officer | Convert | 2,000 |